MedImprove SRL
3.3 FTEMedImprove reported total assets of €2.26m at the end of the 2025 financial year (annual accounts filed with the NBB on 19 May 2026), with 3.3 full-time equivalents.
The score of MedImprove shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +125 % Total assets +694 % Headcount (avg FTE) +230 %
Accounts of the company itself (not consolidated).
The full file covers 5 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
MedImprove's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 176,363 € | ||||
| Equity | 301,052 € | ||||
| Cash | 252,371 € | ||||
| EBITDA | 408,527 € | ||||
| Total assets | €2.26m |
Filed annual accounts
- Year ended 31 Dec 2025filed on 19 May 2026
- Year ended 31 Dec 2024filed on 03 Jul 2025
- Year ended 31 Dec 2023filed on 05 Jul 2024
- Year ended 31 Dec 2022filed on 25 Jul 2023
- Year ended 31 Dec 2021filed on 29 Jul 2022
MedImprove's financial analysis
- Solvency13.3%sector median: 60.4%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of MedImprove
MedImprove's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0758.914.241
- VAT number
- BE0758914241
- Peppol
- Registered · 0208:0758914241 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 30 Nov 2020
- Registered office
- 2640 Mortsel
- Size
- Micro · 3.3 FTE
- Latest accounts
- 2025 · filed on 19 May 2026
- Activity
- Research and experimental development on biotechnology (NACE 72101)
MedImprove (SRL) has been based in Mortsel since 2020, active in: research and experimental development on biotechnology. For 2025, it reports a net profit of 176,363 € and equity of 301,052 €; its revenue is not published. With 3.3 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 13.3%, below the median of its sector (60.4%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to MedImprove
Companies in the same business, of comparable size and area, outside its group.
- Dr. Simons - Dr. Annaert Research and experimental development on natural sciences and engineering Lummen · balance sheet €1.34m
- Desmyter Orthopedie Medical specialists activities Destelbergen · balance sheet €2.46m
- Dokter Jacques van Huysse Medical specialists activities Damme · balance sheet €1.97m
- Dr. Borny Filip Medical specialists activities Kortrijk · balance sheet €1.40m
- Dr. P. van Hauthem Medical specialists activities Mechelen · balance sheet €1.21m
- Dr. Heyse Catherine Medical specialists activities Wortegem-Petegem · balance sheet €2.25m
- Dr. Lieven WOSTYN Research and experimental development on natural sciences and engineering Koksijde · balance sheet €3.05m
- Libeer Christophe BV Medical specialists activities Bonheiden · balance sheet €1.02m
Frequently asked questions about MedImprove
What is the revenue of MedImprove?
MedImprove files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of MedImprove?
In Belgium, the VAT number is the company number prefixed with BE: BE0758914241 for MedImprove, if the company is VAT-registered. Its company number (CBE) is 0758.914.241.
Where is the registered office of MedImprove?
According to the CBE register, the registered office of MedImprove is in 2640 Mortsel.
What is the equity of MedImprove?
At the close of the 2025 financial year, the equity of MedImprove amounts to 301,052 €, a solvency of 13.3% of total assets.
How many people work at MedImprove?
3.3 full-time equivalents on average according to the 2025 social balance sheet.
Who manages MedImprove?
The register lists 5 active mandates at MedImprove. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of MedImprove
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →